Physician profile
Stephen J Kovach
NPI 1255463683
$825,212.74
in general payments reported to CMS, 2019-2025
23 companies · $228K in 2025
The $228K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87K · 2020: $62K · 2021: $64K · 2022: $78K · 2023: $143K · 2024: $164K · 2025: $228K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $301K · Consulting Fee: $158K · Travel and Lodging: $55K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $10K · Food and Beverage: $10K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $301,073.60 |
| Consulting Fee | $158,440.00 |
| Travel and Lodging | $55,149.79 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $10,400.00 |
| Food and Beverage | $10,234.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $570,909.79 | 2019-2025 | Phasix Mesh, Arista |
| Integra Lifesciences Corporation | $118,164.21 | 2019-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| W. L. Gore & Associates, INC. | $80,637.25 | 2019-2025 | Gore Enform Preperitoneal Biomaterial, Gore Synecor Biomaterial, Gore Bio-A Tissue Reinforcement |
| Checkpoint Surgical, INC | $23,170.20 | 2020-2025 | Checkpoint Stimulators |
| Allergan, INC. | $14,619.01 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $7,084.31 | 2019-2022 | |
| Kci USA, INC. | $6,854.04 | 2021 | |
| Becton, Dickinson and Company | $1,542.51 | 2023-2025 | Phasix Mesh |
| Abbvie INC. | $906.25 | 2022 | |
| Tela Bio, INC. | $577.36 | 2019-2022 | |
| Polarityte, INC. | $173.14 | 2019 | |
| Rti Surgical, INC | $122.24 | 2025 | |
| Sientra, INC. | $114.66 | 2019 | |
| Axogen | $96.57 | 2024 | Axoguard Nerve Protector, Axoguard Nerve Connector, Avance Nerve Graft |
| Intuitive Surgical, INC. | $38.22 | 2021 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $35.51 | 2024 | |
| Aroa Biosurgery Incorporated | $32.17 | 2023 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $25.26 | 2024 | |
| Medtronic, INC. | $24.63 | 2025 | Rapidvac |
| Solventum Corporation | $23.44 | 2025 | Activ.A.C. |
| Biocomposites INC | $21.96 | 2025 | Stimulan |
| Misonix INC | $20.94 | 2019 | |
| Smith+Nephew, INC. | $19.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kovach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.